Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions-Reference-Cited by-同舟云学术

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

Published:2014-06 Issue:6 Volume:14 Page:498-509
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Roberts Jason A,Abdul-Aziz Mohd H,Lipman Jeffrey,Mouton Johan W,Vinks Alexander A,Felton Timothy W,Hope William W,Farkas Andras,Neely Michael N,Schentag Jerome J,Drusano George,Frey Otto R,Theuretzbacher Ursula,Kuti Joseph L

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference146 articles.

1. Do we understand the impact of altered physiology, consequent interventions and resultant clinical scenarios in the intensive care unit? The antibiotic story;Lipman;Anaesth Intensive Care,2011

2. Pharmacokinetic issues for antibiotics in the critically ill patient;Roberts;Crit Care Med,2009

3. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003;Dombrovskiy;Crit Care Med,2007

4. Intensity of continuous renal-replacement therapy in critically ill patients;Bellomo;N Engl J Med,2009

5. Intensive versus conventional glucose control in critically ill patients;Finfer;N Engl J Med,2009

Cited by 776 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial infusion practices within intensive care units: Carbapenem infusion preparation and administration process errors;Intensive and Critical Care Nursing;2025-02

2. Molecular targets and pharmacodynamics for bactericidal and bacteriostatic activity;Nanotechnology Tools for Infection Control;2025

3. The effects of single and multiple resistance mechanisms on bacterial response to meropenem;Clinical Microbiology and Infection;2024-10

4. Artificial Intelligence to Close the Gap between Pharmacokinetic/Pharmacodynamic Targets and Clinical Outcomes in Critically Ill Patients: A Narrative Review on Beta Lactams;Antibiotics;2024-09-06

5. Precision Dosing of Meropenem in Adults with Normal Renal Function: Insights from a Population Pharmacokinetic and Monte Carlo Simulation Study;Antibiotics;2024-09-05